Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Alvotech (NASDAQ:ALVO) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Alvotech announces European launch of biosimilar to Simponi [Seeking Alpha]
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma [Yahoo! Finance]